JEAN VOLATIER

About JEAN VOLATIER

Jean Volatier is the Chief Financial Officer of Inventiva, a French listed biopharmaceutical company focused on developing innovative therapies for unmet medical needs. He joined Inventiva in August 2012 and has since played a central role in the company’s financial structuring, budget discipline, and governance framework, particularly in the context of a capital-intensive clinical development model. In April 2026, Inventiva announced an organizational change under which Volatier will move into the role of EVP Finance & Corporate Social Responsibility, underscoring the company’s continued confidence in his expertise and institutional knowledge. Before joining Inventiva, Volatier built a broad career in finance leadership across industrial, consumer, pharmaceutical, and advisory environments. He started his career at PricewaterhouseCoopers, where he worked from 1989 to 1996 in Paris and Philadelphia. He then held controlling responsibilities at URGO Soins & Santé, followed by international finance leadership roles at Laboratoires Fournier from 1999 to 2006. He went on to serve as Chief Financial Officer of Groupe Soufflet from 2006 to 2008, acted as interim CFO of NAOS in 2010, and later worked as a senior consultant for I Care Environnement in 2011. This trajectory reflects deep experience in corporate finance, performance management, cash and liquidity oversight, international operations, and organizational transformation. Academically, he holds a Magistère in Management Sciences from Université Paris IX Dauphine, the D.E.S.C.F., and an Executive Master in Global CSR Management from Mines ParisTech. His background combines strong accounting and financial expertise with a clear understanding of sustainability and corporate responsibility issues, which is especially relevant in a publicly listed biopharmaceutical company. At Inventiva, Volatier has been involved throughout the company’s successive development stages, supporting financing initiatives and the scaling-up of internal capabilities. His long tenure and deep knowledge of the organization make him a key figure in maintaining financial continuity and strategic credibility with investors, lenders, and other stakeholders.